Compare TMDX & CMPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | CMPR |
|---|---|---|
| Founded | 1998 | 1994 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 2019 | 2005 |
| Metric | TMDX | CMPR |
|---|---|---|
| Price | $73.64 | $97.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $148.22 | $86.50 |
| AVG Volume (30 Days) | ★ 969.8K | 178.1K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 382.18 | N/A |
| EPS | 0.20 | ★ 2.81 |
| Revenue | $605,494,000.00 | ★ $3,403,079,000.00 |
| Revenue This Year | $24.25 | $10.43 |
| Revenue Next Year | $18.75 | $5.46 |
| P/E Ratio | $355.65 | ★ $34.64 |
| Revenue Growth | ★ 37.13 | 3.38 |
| 52 Week Low | $60.11 | $47.95 |
| 52 Week High | $156.00 | $106.58 |
| Indicator | TMDX | CMPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 50.49 |
| Support Level | $64.87 | $93.51 |
| Resistance Level | $79.60 | $106.14 |
| Average True Range (ATR) | 3.13 | 3.42 |
| MACD | 0.02 | -0.47 |
| Stochastic Oscillator | 34.57 | 32.44 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.